Jennings, C.; Parkin, N.T.; Zaccaro, D.J.; Capina, R.; Sandstrom, P.; Ji, H.; Brambilla, D.J.; Bremer, J.W.
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. Viruses 2020, 12, 1456.
https://doi.org/10.3390/v12121456
AMA Style
Jennings C, Parkin NT, Zaccaro DJ, Capina R, Sandstrom P, Ji H, Brambilla DJ, Bremer JW.
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. Viruses. 2020; 12(12):1456.
https://doi.org/10.3390/v12121456
Chicago/Turabian Style
Jennings, Cheryl, Neil T. Parkin, Daniel J. Zaccaro, Rupert Capina, Paul Sandstrom, Hezhao Ji, Donald J. Brambilla, and James W. Bremer.
2020. "Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing" Viruses 12, no. 12: 1456.
https://doi.org/10.3390/v12121456
APA Style
Jennings, C., Parkin, N. T., Zaccaro, D. J., Capina, R., Sandstrom, P., Ji, H., Brambilla, D. J., & Bremer, J. W.
(2020). Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. Viruses, 12(12), 1456.
https://doi.org/10.3390/v12121456